Anti-aging treatments slow propagation of synucleinopathy by restoring lysosomal function.
Ontology highlight
ABSTRACT: Aging is the major risk factor for neurodegenerative diseases that are also associated with impaired proteostasis, resulting in abnormal accumulation of protein aggregates. However, the role of aging in development and progression of disease remains elusive. Here, we used Caenorhabditis elegans models to show that aging-promoting genetic variations accelerated the rate of cell-to-cell transmission of SNCA/α-synuclein aggregates, hallmarks of Parkinson disease, and the progression of disease phenotypes, such as nerve degeneration, behavioral deficits, and reduced life span. Genetic and pharmacological anti-aging manipulations slowed the spread of aggregates and the associated phenotypes. Lysosomal degradation was significantly impaired in aging models, while anti-aging treatments reduced th
SUBMITTER: Kim DK
PROVIDER: S-EPMC5079673 | biostudies-literature | 2016 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA